| 221 |
|
NEUROPHARMACOLOGY - Prostaglandin A1 Protects Striatal Neurons against Excitotoxic Injury in Rat Striatum/
|
Qin, Zheng-Hong
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 222 |
|
NEUROPHARMACOLOGY - Protein Kinase C and Intracellular Calcium Are Required for Amphetamine-Mediated Dopamine Release via the Norepinephrine Transporter in Undifferentiated PC12 Cells/
|
Kantor, Lana
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 223 |
|
NEUROPHARMACOLOGY - Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with (125I)7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals/
|
Stanwood, Gregg D
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 224 |
|
NEUROPHARMACOLOGY - Reboxetine Modulates the Firing Pattern of Dopamine Cells in the Ventral Tegmental Area and Selectively Increases Dopamine Availability in the Prefrontal Cortex/
|
Linn�r, Love
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 225 |
|
NEUROPHARMACOLOGY - Regional Patterns of Compensation following Genetic Deletion of Either 5-Hydroxytryptamine1A or 5-Hydroxytryptamine1B Receptor in the Mouse/
|
Knobelman, Deborah A
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 226 |
|
NEUROPHARMACOLOGY - Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine/
|
Zhu, Meng-Yang
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 227 |
|
NEUROPHARMACOLOGY - Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants/
|
Brown, Jeffrey M
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 228 |
|
NEUROPHARMACOLOGY - Retro-Inverso Prosaptide Peptides Retain Bioactivity, Are Stable In Vivo, and Are Blood-Brain Barrier Permeable/
|
Taylor, Eve M
|
Williams ＆ Wilkins
|
2000
|
|
|
|
| 229 |
|
NEUROPHARMACOLOGY - Rewarding Properties of Methylphenidate: Sensitization by Prior Exposure to the Drug and Effects of Dopamine D1- and D2-Receptor Antagonists/
|
Meririnne, Esa
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 230 |
|
NEUROPHARMACOLOGY - S18616, a Highly Potent Spiroimidazoline Agonist at a2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine/
|
Millan, Mark J
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 231 |
|
NEUROPHARMACOLOGY - S18616, a Highly Potent, Spiroimidazoline Agonist at a2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine/
|
Millan, Mark J
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 232 |
|
NEUROPHARMACOLOGY - S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine/
|
Millan, Mark J
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 233 |
|
NEUROPHARMACOLOGY - S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine/
|
Millan, Mark J
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 234 |
|
NEUROPHARMACOLOGY - SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia/
|
Barone, F C
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 235 |
|
NEUROPHARMACOLOGY - SEA0400, a Novel and Selective Inhibitor of the Na+-Ca2+ Exchanger, Attenuates Reperfusion Injury in the in Vitro and in Vivo Cerebral Ischemic Models/
|
Matsuda, Toshio
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 236 |
|
NEUROPHARMACOLOGY - Selective and Divergent Regulation of Cortical 5-HT2A Receptors in Rabbit/
|
Aloyo, Vincent J
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 237 |
|
NEUROPHARMACOLOGY - Selective Blockade of Neurokinin-2 Receptors Produces Antidepressant-Like Effects Associated with Reduced Corticotropin-Releasing Factor Function/
|
Steinberg, R�gis
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 238 |
|
NEUROPHARMACOLOGY - Selective Dopamine Receptor Stimulation Differentially Affects (3H)Arachidonic Acid Incorporation, a Surrogate Marker for Phospholipase A2-Mediated Neurotransmitter Signal Transduction, in a Rodent Model of Parkinson's Disease/
|
Hayakawa, Takanori
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 239 |
|
NEUROPHARMACOLOGY - Serotonergic Manipulations Both Potentiate and Reduce Brain Stimulation Reward in Rats: Involvement of Serotonin-1A Receptors/
|
Harrison, Amanda A
|
Williams ＆ Wilkins
|
2001
|
|
|
|
| 240 |
|
NEUROPHARMACOLOGY - Serotonergic Modulation of Rat Pineal Gland Activity: In Vivo Evidence for a 5-Hydroxytryptamine2C Receptor Involvement/
|
Steardo, Luca
|
Williams ＆ Wilkins
|
2000
|
|
|
|
기사
(329)
